Generic Substitution Noninterference Act

Summary

Generic Substitution Noninterference Act This bill prohibits drug manufacturers from helping or directing health care providers to limit prescriptions to brand-name drugs when generic versions are available. The Federal Trade Commission and states may enforce this bill through civil actions.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

1. 7 April 2022

   Introduced

   Referred to the House Committee on the Judiciary.

   Source: IntroReferral

2. 7 April 2022

   Introduced

   Introduced in House

   Source: IntroReferral

3. 7 April 2022

   Introduced

   Introduced in House

   Source: IntroReferral

4. 1 November 2022

   Referred

   Referred to the Subcommittee on Antitrust, Commercial, and Administrative Law.

   Source: Committee

Votes

No vote records are attached yet.

Versions

• Introduced in House · 7 April 2022 · Official file

Documents

3 official files

• Introduced in House (text)

  Introduced in House · EN · 7 April 2022

  ViewDownloadOpen at official source

• Introduced in House (PDF)

  Introduced in House · EN · 7 April 2022

  ViewDownloadOpen at official source

• Introduced in House

  summary · EN · 7 April 2022

  Open at official source

Sponsors

• CAROLYN MALONEY · D · Sponsor
• David Cicilline · D · Sponsor
• Rep. Nadler, Jerrold [D-NY-12] · D · Sponsor
• Sen. Welch, Peter [D-VT] · D · Sponsor
• Rep. Schakowsky, Janice D. [D-IL-9] · D · Sponsor
• Katie Porter · D · Sponsor
• Rep. DeSaulnier, Mark [D-CA-10] · D · Sponsor
• Rep. Raskin, Jamie [D-MD-8] · D · Sponsor
• · hsju00 · Standing

Related records

No cross-record relationships stored yet.